The Ibn Sina Pharmaceutical Industry Limited announced earnings results for the third quarter ended March 31, 2019. For the third quarter, the company announced sales was BDT 1,247.190 million compared to BDT 1,028.127 million a year ago. Operating income was BDT 94.923 million compared to BDT 77.807 million a year ago. Net income was BDT 62.145 million compared to BDT 48.277 million a year ago. Basic earnings per share was BDT 1.99 compared to BDT 1.55 a year ago. For the nine months, sales was BDT 3,818.662 million compared to BDT 3,497.907 million a year ago. Operating income was BDT 356.472 million compared to BDT 318.255 million a year ago. Net income was BDT 248.421 million compared to BDT 217.383 million a year ago. Basic earnings per share was BDT 7.95 compared to BDT 6.96 a year ago.